1. |
Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease:a neglected priority for global health[J]. Hypertension, 2007, 50(6): 991-997.
|
2. |
(6757): 403-408.
|
3. |
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000[J]. JAMA, 2003, 290(2): 199-206.
|
4. |
Safian RD, Textor SC. Renal-artery stenosis[J]. N Engl J Med,.
|
5. |
ASTRAL Investigators;Wheatley K, Ives N, et al. Revascularization versus medical therapy for renal-artery stenosis[J]. N Engl J Med, 2009, 361(20): 1953-1962.
|
6. |
Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial[J]. Ann Intern Med, 2009, 150(12): 840-848.
|
7. |
European Stroke Organisation;Tendera M, Aboyans V,et al. ESC guidelines on the diagnosis and treatment of peripheral arterydiseases: document covering atherosclerotic disease of extracranialcarotid and vertebral, mesenteric, renal, upper and lower extre-mity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(22): 2851-2906.
|
8. |
Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1 266 cases[J]. J Am Med Assoc, 1953, 152(16): 1501-1504.
|
9. |
Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in thetreatment of hypertension; review of 122 cases[J]. Lancet, 1953,.
|
10. |
Barajas L. Innervation of the renal cortex[J]. Fed Proc, 1978, 37(5): 1192-1201.
|
11. |
Bell-Reuss E, Trevino DL, Gottschalk CW. Effect of renal symp-athetic nerve stimulation on proximal water and sodium reabsorption[J]. J Clin Invest, 1976, 57(4): 1104-1107.
|
12. |
Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion[J]. Klin Wochenschr, 1989, 67(17): 858-864.
|
13. |
Zanchetti AS. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension[J]. Circulation, 1977, 56(5): 691-698.
|
14. |
Barajas L, Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin[J]. Can J Physiol Pharmacol, 1992, 70(5): 735-749.
|
15. |
Grassi G, Seravalle G, Ghiadoni L, et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease[J]. Clin J Am Soc Nephrol, 2011, 6(11): 2620-2627.
|
16. |
Kopp UC. Endothelin in the control of renal sympathetic nerve activity[J]. Contrib Nephrol, 2011, 172: 107-119.
|
17. |
Bruno RM, Ghiadoni L, Seravalle G, et al. Sympathetic regul-ation of vascular function in health and disease[J]. Front Physiol,.
|
18. |
Rahmouni K. Leptin-induced sympathetic nerve activation: sign-aling mechanisms and cardiovascular consequences in obesity[J]. Curr Hypertens Rev, 2010, 6(2): 104-209.
|
19. |
Kumagai H, Oshima N, Matsuura T, et al. Importance of rostralventrolateral medulla neurons in determining efferent sympatheticnerve activity and blood pressure[J]. Hypertens Res, 2012, 35(2): 132-141.
|
20. |
Davisson RL, Zimmerman MC. AngiotensinⅡ, oxidant signaling, and hypertension: down to a T?[J]. Hypertension, 2010, 55(2): 228-230.
|
21. |
Dibona GF. Physiology in perspective: the wisdom of the body. Neural control of the kidney[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 289(3): R633-R641.
|
22. |
Dibona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure[J]. Am J Physiol, 1991, 260(2 Pt 2): R298-R305.
|
23. |
Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure[J]. Hypertension, 1995, 25(4 Pt 2): 878-882.
|
24. |
Grimson KS. Total thoracic and partial to total lumbar sympath-ectomy and celiac ganglionectomy in the treatment of hypertension[J]. Ann Surg, 1941, 114(4): 753-775.
|
25. |
Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension[J]. Am J Cardiol, 2010,.
|
26. |
Symplicity HTN-2 Investigators;Esler MD, Krum H, et al. Renalsympathetic denervation in patients with treatment-resistant hype-rtension (The Symplicity HTN-2 Trial): a randomised controlled trial[J]. Lancet, 2010, 376(9756): 1903-1909.
|
27. |
Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373(9671): 1275-1281.
|
28. |
Gan XB, Duan YC, Xiong XQ, et al. Inhibition of cardiac symp-athetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure[J]. PLoS One,.
|
29. |
Mahfoud F, Lenski M, Böhm M. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?[J]. Future Cardiol, 2011, 7(5): 591-594.
|
30. |
Oparil S, Narkiewicz K, Kjeldsen S, et al. Renal nerve ablation:emerging role in therapeutics[J]. Blood Press, 2011, 20(5): 253-255.
|
31. |
Hansen JM, Abildgaard U, Fogh-Andersen N, et al. The trans-planted human kidney does not achieve functional reinnervation[J]. Clin Sci (Lond), 1994, 87(1): 13-20.
|
32. |
Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension[J]. N Engl J Med,.
|
33. |
Rassaf T, Westenfeld R, Balzer J, et al. Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation[J]. Eur J Med Res, 2010, 15 Suppl 2: 83-87.
|
34. |
Grisk O, Gröne HJ, Rose HJ, et al. Sympathetic reinnervation of rat kidney grafts[J]. Transplantation, 2001, 72(6): 1153-1155.
|
35. |
Stefanadis C. Renal denervation in resistant hypertension: radiofrequency ablation and chemical denervation[J]. Hellenic J Cardiol, 2011, 52(6): 481-482.
|
36. |
Mahfoud F, Himmel F, Ukena C, et al. Treatment strategies for resistant arterial hypertension[J]. Dtsch Arztebl Int, 2011, 108(43): 725-731.
|
37. |
Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial[J]. Clin Cardiol, 2012, 35(9): 528-535.
|
38. |
(4): 570-576.
|
39. |
, 344(6): 431-442.
|
40. |
, 361(9): 932-934.
|
41. |
, 6(10): e25784.
|
42. |
, 3: 284.
|